Content about Imiglucerase

February 16, 2011

French drug maker Sanofi-Aventis will acquire U.S. biotech giant Genzyme for $20.1 billion, under an agreement the two companies announced Wednesday.

CAMBRIDGE, Mass. — French drug maker Sanofi-Aventis will acquire U.S. biotech giant Genzyme for $20.1 billion, under an agreement the two companies announced Wednesday.

October 7, 2010

The board of directors of Genzyme again has rejected a buyout offer by French drug...

CAMBRIDGE, Mass. The board of directors of Genzyme again has rejected a buyout offer by French drug maker Sanofi-Aventis, Genzyme said Thursday.

The biotech company’s board unanimously turned down the hostile offer Sanofi made Monday to acquire Genzyme for $18.5 billion, or $69 per share, saying it was “opportunistic” and undervalued the company.

 

October 3, 2010

French drug maker Sanofi-Aventis has launched a hostile takeover bid to take over Cambridge, Mass.-based...

NEW YORK French drug maker Sanofi-Aventis has launched a hostile takeover bid to take over Cambridge, Mass.-based biotech company Genzyme, according to published reports.

 

The Associated Press reported Monday that Sanofi would try to acquire the company for $18.5 billion, or $69 per share. Genzyme previously had rejected Sanofi’s friendly offer for the same amount.

 

 

July 7, 2010

Generic drug maker Hospira will fill and package several drugs for Genzyme, according to published...

May 23, 2010

Biotech company Genzyme will pay $175 million to the federal government as part of an...

March 23, 2010

Genzyme Corp. will have to submit to inspections of one of its plants by the...

February 25, 2010

The Food and Drug Administration has approved a new drug for treating a rare genetic...